IceCure Medical (ICCM) vs Vivos Therapeutics (VVOS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
IceCure Medical is the larger company by market cap ($5.2 million vs $5.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ICCM | VVOS |
|---|---|---|
| Share price | $1.13 | $0.1495 |
| Market cap | $5.24M | $5.02M |
| 1-day change | -1.74% | -0.99% |
| EPS (TTM) | $-6.84 | $-1.88 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $30.30 | $3.28 |
| 52-week low | $1.05 | $0.129 |
| Distance from 52-week high | -96.27% | -95.44% |
| Analyst consensus | none | none |
| Avg. price target upside | +1906.19% | +1318.06% |
| Average volume | 136.91K | 12.57M |
| Shares outstanding | 4.64M | 33.61M |
| Employees | 67 | 268 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About IceCure Medical
ICCM stock →IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.
Health Care · Medical/Dental Instruments · 67 employees
About Vivos Therapeutics
VVOS stock →Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.
Health Care · Medical/Dental Instruments · 268 employees
ICCM vs VVOS FAQ
Which is bigger, IceCure Medical or Vivos Therapeutics?
IceCure Medical (ICCM) is larger, with a market capitalization of $5.24M compared with $5.02M for Vivos Therapeutics (VVOS).
Are IceCure Medical and Vivos Therapeutics in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.